News

In a recent Perspective, Daniel Drucker explores the expanding scope of glucagon-like peptide-1 (GLP-1) therapies, highlighting their emerging potential to...

An international research team has unveiled a significant connection between unhealthy sleep patterns and an elevated risk of Type 2...

A recent study conducted by researchers from the UK and the Czech Republic reveals that children diagnosed with type 1...

In a significant move to enhance diabetes care in Libya, the Prime Minister of the Government of National Unity, Abdul...

Research conducted by Helmholtz Munich in Germany has revealed that COVID-19 infection nearly doubled the rate of progression to type...

Recent research suggests that certain diets could help mitigate inflammation and reduce the risk of heart disease in adults with...

New research highlights the critical role of optimal sleep in reducing the risk of microvascular complications in individuals with type...

In a groundbreaking study published in the journal Nutrition and Metabolism, researchers have identified a significant link between dried fruit...

MADRID, July 11, 2024 / DIABETOLOGIA / -- New research presented at the upcoming Annual Meeting of the European Association...

SHENZHEN, China, July 12, 2024 /PRNewswire/ -- The 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx) Summit, organized by...

Periodontitis, a prevalent oral disorder characterized by inflammation of the soft tissue, loss of periodontal attachment, and potential tooth loss,...

In a recent study published in PLOS Medicine, Chinese researchers explored the long-term health benefits of maintaining non-diabetic status following...

Recent research highlights that combining GLP-1 drugs, such as Ozempic, with SGLT2 diabetes medications can significantly reduce the risks of...

Type 2 diabetes is a progressive disease, meaning that over time, managing the condition may require changes in treatment. Whether...

Gestational diabetes mellitus (GDM) was a prominent focus at the American Diabetes Association conference, with significant advancements in research. GDM...

Scientists at the University of Nottingham, UK, have conducted a short-term intervention study demonstrating the effectiveness of a very low-calorie...

New research has revealed that the combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists...

Researchers have identified circulating microRNAs as potential predictors of treatment response in young individuals with type 2 diabetes, marking a...

A recent study conducted by researchers at Brigham and Women’s Hospital has shed light on the potential role of the...

The INHALE-3 study, showcased at the American Diabetes Association's 84th Scientific Sessions in Orlando, Florida, underscores the necessity of personalized...